We are live on
!
Find out more
CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.67B
1-Year Est. Return
89%
This Fund
S&P 500
This Quarter
Est. Return
+22.56%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$295M
AUM Growth
+$46.7M
(+19%)
Cap. Flow
+$5.84M
Cap. Flow
% of AUM
1.98%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$6.09M |
| 2 |
PayPal
PYPL
|
+$4.84M |
| 3 |
STAAR Surgical
STAA
|
+$3.72M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$3.18M |
| 5 |
Microsoft
MSFT
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$7.85M |
| 2 |
iQIYI
IQ
|
+$7.2M |
| 3 |
ON Semiconductor
ON
|
+$4.1M |
| 4 |
Apple
AAPL
|
+$2.75M |
| 5 |
uniQure
QURE
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Edgewise Therapeutics
EWTX
$4.73B
| $5.72K | ﹤0.01% |
857
+215
| +33% | +$1.99K |
|
352
Nurix Therapeutics
NRIX
$2.76B
| $5.69K | ﹤0.01% |
641
+162
| +34% | +$1.69K |
|
353
SIGA Technologies
SIGA
$206M
| $5.69K | ﹤0.01% |
989
+247
| +33% | +$1.65K |
|
354
Erasca
ERAS
$6.45B
| $5.62K | ﹤0.01% |
1,867
+624
| +50% | +$2.27K |
|
|
RPTX
355
DELISTED
Repare Therapeutics
RPTX
| $5.61K | ﹤0.01% |
570
+144
| +34% | +$1.65K |
|
356
Scholar Rock
SRRK
$6.55B
| $5.6K | ﹤0.01% |
700
+175
| +33% | +$1.77K |
|
357
Ocular Therapeutix
OCUL
$2.25B
| $5.5K | ﹤0.01% |
1,043
+261
| +33% | +$1.24K |
|
358
Cullinan Oncology
CGEM
$1.26B
| $5.45K | ﹤0.01% |
533
+68
| +15% | +$750 |
|
|
IGMS
359
DELISTED
IGM Biosciences
IGMS
| $5.43K | ﹤0.01% |
395
+99
| +33% | +$2.05K |
|
|
TSVT
360
DELISTED
2seventy bio
TSVT
| $5.23K | ﹤0.01% |
513
+127
| +33% | +$1.45K |
|
361
Vanda Pharmaceuticals
VNDA
$314M
| $5.22K | ﹤0.01% |
769
+194
| +34% | +$1.36K |
|
362
Zscaler
ZS
$28.7B
| $5.14K | ﹤0.01% |
+44
| New | +$5.28K |
|
|
ALLK
363
DELISTED
Allakos
ALLK
| $5.13K | ﹤0.01% |
1,154
+289
| +33% | +$1.85K |
|
364
Monte Rosa Therapeutics
GLUE
$1.36B
| $5.11K | ﹤0.01% |
656
+164
| +33% | +$1.14K |
|
365
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $5.04K | ﹤0.01% |
468
+117
| +33% | +$1.54K |
|
|
EGRX
366
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.02K | ﹤0.01% |
177
+45
| +34% | +$1.34K |
|
|
KLRS
367
Kalaris Therapeutics
KLRS
$93.7M
| $4.99K | ﹤0.01% |
55
+14
| +34% | +$1.78K |
|
|
ALPN
368
DELISTED
Alpine Immune Sciences Inc
ALPN
| $4.81K | ﹤0.01% |
623
+156
| +33% | +$1.24K |
|
369
Tango Therapeutics
TNGX
$4.31B
| $4.72K | ﹤0.01% |
1,195
+299
| +33% | +$1.74K |
|
370
Nautilus Biotechnolgy
NAUT
$114M
| $4.69K | ﹤0.01% |
1,692
+425
| +34% | +$891 |
|
371
SiriusXM
SIRI
$9.59B
| $4.67K | ﹤0.01% |
+118
| New | +$5.65K |
|
|
MRNS
372
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $4.64K | ﹤0.01% |
672
+187
| +39% | +$1.17K |
|
373
Tarsus Pharmaceuticals
TARS
$3.07B
| $4.55K | ﹤0.01% |
362
+91
| +34% | +$1.33K |
|
|
NGM
374
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $4.54K | ﹤0.01% |
1,112
+282
| +34% | +$1.3K |
|
|
OMGA
375
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $4.5K | ﹤0.01% |
746
+258
| +53% | +$1.8K |
|
Similar funds
HA
JPM
CPO
LCI
GWM
JIP
RMC
GACM
China Universal Asset Management Company's Q1 2023 Portfolio in Review
As of Q1 2023, China Universal Asset Management Company held 456 positions worth $295M, up 19% from $249M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
China Universal Asset Management Company's Q1 2023 filing shows 65 new, 317 increased, 38 reduced and 9 closed positions. Its largest new stake was Baidu: 20,500 shares worth $3.09M. The largest sale was Pinduoduo, an estimated $7.85M.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- China Universal Asset Management Company's largest Q1 2023 buy was Baidu: 20,500 shares worth $3.09M.
- China Universal Asset Management Company added most to NVIDIA in Q1 2023, an estimated $6.09M increase.
- China Universal Asset Management Company's biggest Q1 2023 reduction was Pinduoduo, cutting an estimated $7.85M.
- China Universal Asset Management Company fully exited Tower Semiconductor in Q1 2023, selling an estimated $1.94M.
- China Universal Asset Management Company's ten largest holdings make up 32% of its $295M portfolio in Q1 2023.
- China Universal Asset Management Company opened 65 new positions and closed 9 in Q1 2023.
- China Universal Asset Management Company's portfolio value rose 19% quarter-over-quarter to $295M.
Based on China Universal Asset Management Company's 13F filing for Q1 2023, filed 28 Apr 2023.